samedan logo
 
 
spacer
home > pmps > spring 2009 > fda technology transformation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

FDA Technology Transformation

Historically, interactions between the FDA and the companies it regulates have involved the creation, printing and delivery of volumes of paper documents. These documents may have been delivered as part of an application or reviewed on-site in the course of an inspection.

Over the last few years, the FDA and industry have recognised the need for a modern, well-integrated, reliable, efficient and affordable electronic information infrastructure to support FDA administrative, regulatory and business operations. To achieve this transformational goal, the agency has embarked on a series of organisational and information technology activities. These initiatives are aimed at advancing ongoing electronic communication and interactions between the agency, the public and the companies that the FDA regulates.

As Dr Armando Oliva, FDA Deputy Director for Bioinformatics, commented: “it’s fair to say that the Agency is actively moving toward an electronic world where all regulated product information comes in electronically. I couldn’t tell when that is going to happen, but certainly there are active discussions underway to move to an ‘all electronic submission environment’ for all FDA-regulated product information, whether it be product quality, manufacturing, pre-market or post-market data” (1).


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Daniel R Matlis is the Founder and President of Axendia, Inc, a advisor to life science executives on business, technology and regulatory issues. Dan’s almost 20-year career in the life sciences industry has included projects in R&D, operations, regulatory compliance, business development and information technology. He started his professional career at a Johnson & Johnson’s Ethicon Company, where he was Technical Owner for Computer Integrated Manufacturing, Automation & IT Engineering Standards and Computer System Compliance. Prior to founding Axendia, Dan was Vice President and General Manager at Stelex (now part of GE Healthcare). He is the chief contributor and editor of Life-Science Panorama – a publication covering business, regulatory and technology issues facing industry executives.
spacer
Daniel R Matlis
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Sample Management Benchmarking Symposium

15 September 2010, Griesheim, Germany

BioStorage Technologies Inc, a global leader in sample management, cold chain logistics and biomaterial storage for the pharmaceutical and biotechnology industries, is hosting a global sample management benchmarking symposium in Griesheim, Germany for biobanking and biospecimen professionals from the pharmaceutical, biotechnology and academic industries.
More info >>

 
News and Press Releases

Almac launch Biomarkers for biopharma

Almac today announced the launch of Biomarkers for biopharma; a range of solutions specifically designed to meet the needs of the biopharma industry. Almac’s solutions are to support biopharma companies in adopting biomarker strategies to enable them to better understand their drug, improve their drug’s success rate, improve the drug’s value and ultimately maximise their drug’s potential.
More info >>

 

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement